News
Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...
With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...
Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
4d
Week99er on MSNRetatrutide (LY3437943): A Comprehensive Review of Its Therapeutic Potential in Obesity and Type 2 Diabetes MellitusThe escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...
Weight loss drugs like Ozempic gained popularity for managing obesity, diabetes, and related chronic conditions, a new study ...
While it is understood that the drugs have also proven to be safe and effective for thousands, the negative issues have led ...
How GLP-1 analogs are reshaping diabetes care and obesity treatment and unlocking potential in cardiovascular, inflammatory, ...
6d
MedPage Today on MSNBy Influencing Inflammation, GLP-1s May Lower Alzheimer's and Dementia RiskIn a plenary session at the annual American Academy of Neurology meeting, Paul Edison, MD, PhD, of Imperial College London in ...
Carbohydrates and protein each offers nutrition and health benefits and can be part of a healthy breakfast. Learn how to fuel the start of your day.
Researchers at the University of Queensland have found that improving the function of the gut microbiome may delay the onset ...
Among patients with diabetes receiving PCI, novel antidiabetic agents may reduce risk for acute kidney injury.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results